Rchr
J-GLOBAL ID:202001008624223273   Update date: Jul. 31, 2023

Inada Koshun

イナダ コウシュン | Inada Koshun
Affiliation and department:
Papers (2):
  • Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages. Journal of Pharmacological Sciences. 2020
  • Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1 expression. Journal of Pharmacological Sciences. 2020
Lectures and oral presentations  (10):
  • Moxifloxacin exacerbates aortic aneurysm and aortic dissection by weakening the aortic media.
    (The 95th Annual Meeting of the Japanese Pharmacological Society 2022)
  • Nalmefene, a reducing alcohol consumption drug, enhanced oxLDL uptake in macrophages and aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice.
    (The 95th Annual Meeting of the Japanese Pharmacological Society 2022)
  • モキシフロキサシンによる大動脈瘤・解離における分化型血管平滑筋細胞マーカー発現減少
    (第74回日本薬理学会西南部会 2021)
  • Moxifloxacin exacerbate aortic aneurysm and aortic dissection by increasing osteopontin protein expressions
    (The 94th Annual Meeting of the Japanese Pharmacological Society 2021)
  • Moxifloxacin elevates the risk of aortic aneurysm and aortic dissection by increasing osteopontin protein expressions in macrophages.
    (The 93th Annual Meeting of the Japanese Pharmacological Society 2020)
more...
Professional career (1):
  • 学士(薬学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page